Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch. // Journal of Substance Use and Addiction Treatment. – URL: https://www.sciencedirect.com/science/article/pii/S2949875926002158?dgcid=rss_sd_all
Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch. Journal of Substance Use and Addiction Treatment. https://www.sciencedirect.com/science/article/pii/S2949875926002158?dgcid=rss_sd_all
“Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch.” Journal of Substance Use and Addiction Treatment.
@article{article55488,
title = {Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch},
journal = {Journal of Substance Use and Addiction Treatment},
url = {https://www.sciencedirect.com/science/article/pii/S2949875926002158?dgcid=rss_sd_all}
}